Simplexa COVID-19 & Flu A/B Direct
Device
DiaSorin Molecular LLC
Total Payments
$15,680
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $15,680 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $15,680 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Simplexa COVID-19 & Flu A/B Direct - PROT.711.00586 (DD20-017) | DiaSorin Molecular LLC | $15,680 | 0 |
Top Doctors Receiving Payments for Simplexa COVID-19 & Flu A/B Direct
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Fort Worth, TX | $15,680 | 1 |
Ad
Manufacturing Companies
- DiaSorin Molecular LLC $15,680
Product Information
- Type Device
- Total Payments $15,680
- Total Doctors 0
- Transactions 1
About Simplexa COVID-19 & Flu A/B Direct
Simplexa COVID-19 & Flu A/B Direct is a device associated with $15,680 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is DiaSorin Molecular LLC.
Payment data is available from 2021 to 2021. In 2021, $15,680 was paid across 1 transactions to 0 doctors.
The most common payment nature for Simplexa COVID-19 & Flu A/B Direct is "Unspecified" ($15,680, 100.0% of total).
Simplexa COVID-19 & Flu A/B Direct is associated with 1 research study, including "Simplexa COVID-19 & Flu A/B Direct - PROT.711.00586 (DD20-017)" ($15,680).